Observer
  • Business
  • Art
  • Lifestyle
Newsletters
  • Business
    • Finance
    • Media
    • Technology
    • Policy
    • Wealth
    • Insights
    • Interviews
  • Art
    • Art Fairs
    • Art Market
    • Art Reviews
    • Auctions
    • Galleries
    • Museums
    • Interviews
  • Lifestyle
    • Nightlife & Dining
    • Style
    • Travel
    • Interviews
  • Power Lists
    • Nightlife & Dining
    • Art
    • A.I.
    • PR
  • About
    • About Observer
    • Advertise With Us
    • Reprints
Newsletters

FDA

A robot hand optimizing medical processes

The Economics of Drug Development: What it Will Really Take to Reduce Drug Prices

Orr Inbar, CEO and co-founder of QuantHealth, unpacks the growing frustration over drug prices and the misperceptions fueling distrust in the pharmaceutical industry. With clinical trials now more expensive and less successful than ever, Inbar explores how A.I.-powered simulations can fundamentally change the economics of drug development, reducing development costs, boosting approval rates and ultimately bringing more affordable treatments to market.
By Orr Inbar
Food and Drug Administration Commissioner (FDA) Martin Makary waits for the start of a press conference.

New FDA Chief Martin Makary Says DOGE Cuts Haven’t Hit Science Staff

The new FDA chief reiterated his commitment to speeding up drug approval processes and run the agency by "gold standard science" and "common sense."
By Sissi Cao
Cellphone with 'Neuralink' logo displayed on screen

Elon Musk’s Neuralink Aims to Implant 10 Times More Brain Chips in 2025

Neuralink recently implanted its brain device into a third patient, according to Elon Musk.
By Alexandra Tremayne-Pengelly
Vaping

The Federal Government’s War on Vaping Comes to New York

By Brian Darling

Juul Labs Brings on Top Trumpworld Talent as Federal Investigators Circle

By Davis Richardson

Why Congress Is Taking Action to Address Teen Smoking

By Matt Borges
NightWare

Severe Nightmares May Soon Be a Thing of the Past Thanks to Your Apple Watch

By Arick Wierson

Here’s How the FDA’s New E-Cigarette Policy Hurts Small Businesses

By Matt Cordio
When depressed people lose access to their antidepressants, it is a life-threatening emergency.

A Man Died Because He Didn’t Have $20—And US Health Care Is to Blame

By Chris Roberts
A surgeon and his team perform surgery

How ‘Right to Try’ Laws Fail Patients Who Need Experimental Medicine

By Peter Pitts
According to the FDA, more than 282 warning letters have been sent to pharmaceutical companies related to manufacturing problems since 2015.

Contaminated Generic Drugs Reveal an Urgent Public Health Crisis

By Peter Pitts
The two main indicators driving tobacco use by teens are availability of product and tobacco use by one or more of their parents.

Vape Me This: A Rational Debate on Teens and E-Cigarettes

By Kerri Toloczko

What the FDA’s Supplement Crackdown Means for Placebo Kingmaker Alex Jones

By Davis Richardson
A complete ban to the ends of stopping underage use of vaping devices is way over the line and infringes on the freedom of adults who choose to use these products.

The FDA Is Overreaching With Its Attempt to Ban Vaping

By Brian Darling

Juul Will Discontinue Its Popular Flavors and Quit Social Media After FDA Crackdown

By Helen Holmes
John Hook formed Impact Biomedicines to carry on an abandoned clinical research.

This 1-Year-Old Pharma Startup Landed a $1B Buyout

By Sissi Cao
Unsplash/Alex Hockett

FDA’s New Patient-Centric Approach Will Help Kids in Need of Miracles

By John Crowley
Unsplash/Dan Gold

Why Putting Calorie Counts on Menus Won’t Change America’s Health

By Francesca Friday
Can the active ingredient in Johnson's baby powder cause cancer?

Johnson & Johnson Ordered to Pay $417 Million in Baby Powder Cancer Suit

By John Bonazzo
Not a Domino's pizza.

Domino’s Pizza Just Won an Award for ‘Putting Profits Before Public Health’

By Merin Curotto
Unsplash/Pineapple Supply Co

Are Pink Pineapples Safe to Eat?

By Dr. Tania Dempsey
Metformin’s low price is an obstacle to its approval.

Big Pharma Ignores Possible Anti-Aging Drug Because It Costs 5 Cents Per Pill

By Michael Sainato
Birth control methods for men have the potential to cut into market for condoms.

Despite Big Pharma’s Lack of Support, Variety of Male Contraceptives on the Horizon

By Michael Sainato
A research specialist tests body fluids searching for evidence of the Zika virus on June 28, 2016.

Scott Gottlieb for FDA Is a Big Win for Science

By John Crowley
More
  • ART
  • BUSINESS
  • LIFESTYLE
  • POWER LISTS
  • INTERVIEWS
  • ABOUT
  • ADVERTISE
  • CONTACT
  • NEWSLETTERS
  • RSS FEEDS
  • SITEMAP
  • TERMS
  • PRIVACY
  • REPRINTS
  • Privacy
  • Terms
  • Cookie Settings
  • Do not sell my data
Powered by WordPress VIP

We noticed you're using an ad blocker.

We get it: you like to have control of your own internet experience.
But advertising revenue helps support our journalism.

To read our full stories, please turn off your ad blocker.
We'd really appreciate it.

How Do I Whitelist Observer?

How Do I Whitelist Observer?

Below are steps you can take in order to whitelist Observer.com on your browser:

For Adblock:

Click the AdBlock button on your browser and select Don't run on pages on this domain.

For Adblock Plus on Google Chrome:

Click the AdBlock Plus button on your browser and select Enabled on this site.

For Adblock Plus on Firefox:

Click the AdBlock Plus button on your browser and select Disable on Observer.com.

Then Reload the Page